René González

University of Miami — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

71h-index58.9kcitations339works2.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Melanoma and MAPK Pathways(129), Cancer Immunotherapy and Biomarkers(111), CAR-T cell therapy research(102), Immunotherapy and Immune Responses(99), Cutaneous Melanoma Detection and Management(72)

Publications337 total

Supplementary table 4 from Targeting MDSC Differentiation Using ATRA: A Phase I/II Clinical Trial Combining Pembrolizumab and All-Trans Retinoic Acid for Metastatic Melanoma
2025Open Access
Supplementary table 1 from Targeting MDSC Differentiation Using ATRA: A Phase I/II Clinical Trial Combining Pembrolizumab and All-Trans Retinoic Acid for Metastatic Melanoma
2025Open Access
Supplementary table 2 from Targeting MDSC Differentiation Using ATRA: A Phase I/II Clinical Trial Combining Pembrolizumab and All-Trans Retinoic Acid for Metastatic Melanoma
2025Open Access
Supplementary Figure S1 from Targeting MDSC Differentiation Using ATRA: A Phase I/II Clinical Trial Combining Pembrolizumab and All-Trans Retinoic Acid for Metastatic Melanoma
2025Open Access
Supplementary Figure S2 from Targeting MDSC Differentiation Using ATRA: A Phase I/II Clinical Trial Combining Pembrolizumab and All-Trans Retinoic Acid for Metastatic Melanoma
2025Open Access
Supplementary table 3 from Targeting MDSC Differentiation Using ATRA: A Phase I/II Clinical Trial Combining Pembrolizumab and All-Trans Retinoic Acid for Metastatic Melanoma
2025Open Access
Supplementary Table 5 from Targeting MDSC Differentiation Using ATRA: A Phase I/II Clinical Trial Combining Pembrolizumab and All-Trans Retinoic Acid for Metastatic Melanoma
2025Open Access
The Notch pathway: A guardian of cell fate during neurogenesis
Current Opinion in Cell Biology·2025· 11 citedOpen Access
Expanding the landscape of oncogenic drivers and treatment options in acral and mucosal melanomas by targeted genomic profiling
International Journal of Cancer·2024· 4 citedOpen Access
Effect of Ibuprofen as an Albumin Binder on Melanoma-Targeting Properties of <sup>177</sup>Lu-Labeled Ibuprofen-Conjugated Alpha-Melanocyte-Stimulating Hormone Peptides
Molecular Pharmaceutics·2024· 6 citedOpen Access
A phase 1 study of triple‐targeted therapy with BRAF, MEK, and AKT inhibitors for patients with <i>BRAF</i>‐mutated cancers
Cancer·2024· 10 citedOpen Access
Health-Related Quality of Life with Pembrolizumab in Patients with Locally Advanced or Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: KEYNOTE-629
Dermatology and Therapy·2023· 2 citedOpen Access
Effects of Polyethylene Glycol and 8-Aminooctanoic Acid Linkers on Melanoma Uptake of [99mTc]-Tricarbonyl-NOTA-Conjugated Lactam-Cyclized Alpha-MSH Peptides
Nuclear Medicine and Biology·2023
B-365 Serum MAGE-A3 and MAGE-A4 Protein Levels as Potential Prognostic Biomarkers for Lung Cancer
Clinical Chemistry·2023Open Access
Durable clinical outcomes in patients (pts) with advanced melanoma and progression-free survival (PFS) ≥3y on nivolumab (NIVO) ± ipilimumab (IPI) or IPI in checkmate 067.
Journal of Clinical Oncology·2023· 1 cited
Introduction of a Polyethylene Glycol Linker Improves Uptake of 67Cu-NOTA-Conjugated Lactam-Cyclized Alpha-Melanocyte-Stimulating Hormone Peptide in Melanoma
Cancers·2023· 6 citedOpen Access
Effects of Polyethylene Glycol and 8-Aminooctanoic Acid Linkers on Melanoma Uptake of [<sup>99m</sup>Tc]Tc-Tricarbonyl-NOTA-Conjugated Lactam-Cyclized α-MSH Peptides
Bioconjugate Chemistry·2023· 4 citedOpen Access
Supplemental Tables 1-8 from Studying Immunotherapy Resistance in a Melanoma Autologous Humanized Mouse Xenograft
2023Open Access
Supplemental Figures 1-12 from Studying Immunotherapy Resistance in a Melanoma Autologous Humanized Mouse Xenograft
2023Open Access
Figure S3 from ALK Inhibitor Response in Melanomas Expressing &lt;i&gt;EML4-ALK&lt;/i&gt; Fusions and Alternate &lt;i&gt;ALK&lt;/i&gt; Isoforms
2023Open Access
page 1 of 17Next →

Frequent Co-authors

F. Stephen Hodi(17), Karl D. Lewis(17), Dirk Schadendorf(14), Jeffrey A. Sosman(13), Georgina V. Long(12), Omid Hamid(11), Jedd D. Wolchok(10), Jeffrey S. Weber(10), Grant A. McArthur(10), Igor Puzanov(10), Steven O’Day(9), Christopher D. Lao(9), Piotr Rutkowski(9), Keith T. Flaherty(9), James Larkin(8), Vanna Chiarion‐Sileni(8), Reinhard Dummer(8), Michael Smylie(8), Iván Márquez‐Rodas(8), Paolo A. Ascierto(8)